Valbiotis Announces the First Visit of the First Patient in the TOTUM•63 Mode of Action Clinical Study Conducted by the INAF, in Partnership With Nestlé Health Science

Valbiotis announced the first visit of the first patient in the TOTUM•63 mode of action clinical study conducted by the Laval University Institute of Nutrition and Functional Foods in Quebec City, in partnership with Nestlé Health Science.